Literature DB >> 10076890

Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins.

G A Jicha1, J M Rockwood, B Berenfeld, M Hutton, P Davies.   

Abstract

Recently, a series of both non-coding (intronic) and coding (exonic) mutations in the tau gene have been linked to a family of autosomal dominant dementias referred to as frontotemporal dementia-17. While linkage analysis has demonstrated that these mutations segregate with disease in affected families, it is unclear how mutant tau proteins could lead to the degenerative cascade seen in frontotemporal dementia-17. The present study demonstrates that coding mutations of tau seen in frontotemporal dementia-17 exhibit altered physical and structural characteristics as determined by reverse phase high performance liquid chromatography and circular dichroism spectroscopy. These data suggest that the previously identified mutations in the tau gene seen in frontotemporal dementia-17 are not merely benign polymorphisms, but may have functional consequences for microtubule binding, microtubule polymerization, and the abnormal aggregation of tau seen in a variety of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076890     DOI: 10.1016/s0304-3940(98)00980-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Tau pathology generated by overexpression of tau.

Authors:  I Grundke-Iqbal; K Iqbal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Activity-Dependent Reconnection of Adult-Born Dentate Granule Cells in a Mouse Model of Frontotemporal Dementia.

Authors:  Julia Terreros-Roncal; Miguel Flor-García; Elena P Moreno-Jiménez; Noemí Pallas-Bazarra; Alberto Rábano; Nirnath Sah; Henriette van Praag; Damiana Giacomini; Alejandro F Schinder; Jesús Ávila; Maria Llorens-Martín
Journal:  J Neurosci       Date:  2019-05-27       Impact factor: 6.167

3.  Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

Authors:  Cathy Andorfer; Christopher M Acker; Yvonne Kress; Patrick R Hof; Karen Duff; Peter Davies
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 4.  Tau in Alzheimer disease and related tauopathies.

Authors:  K Iqbal; F Liu; C-X Gong; I Grundke-Iqbal
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

5.  Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau.

Authors:  Michael DeTure; Li-Wen Ko; Colin Easson; Shu-Hui Yen
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 6.  Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.

Authors:  Khalid Iqbal; Xiaochuan Wang; Julie Blanchard; Fei Liu; Cheng-Xin Gong; Inge Grundke-Iqbal
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

Review 7.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

Review 8.  Developing pharmacological therapies for Alzheimer disease.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  Cell Mol Life Sci       Date:  2007-09       Impact factor: 9.261

Review 9.  Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  J Cell Mol Med       Date:  2007-01-09       Impact factor: 5.310

Review 10.  Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability.

Authors:  Alejandra D Alonso; Leah S Cohen; Christopher Corbo; Viktoriya Morozova; Abdeslem ElIdrissi; Greg Phillips; Frida E Kleiman
Journal:  Front Cell Neurosci       Date:  2018-10-09       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.